ACC.25: Focus on ATTR-CM Content

ACC.25: Focus on ATTR-CM

Rob DillardACC.25: Focus on ATTR-CM | March 28, 2025

Sudden cardiac death increases amid lower daily temperatures.

Rob DillardACC.25: Focus on ATTR-CM | March 28, 2025

Acoramidis therapy significantly increases serum transthyretin in people with ATTR-CM compared with tafamidis.

Rob DillardACC.25: Focus on ATTR-CM | March 28, 2025

Patients with single ventricle heart disease commonly have mental health diagnoses.

Rob DillardACC.25: Focus on ATTR-CM | March 28, 2025

Acoramidis therapy induces a significant increase in serum transthyretin, which is typically lower in ATTRv-CM.